West Family Investments, Inc. - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.

Quarter-by-quarter ownership
West Family Investments, Inc. ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2022$276,000
+1.1%
21,318
+9.7%
0.12%
+6.5%
Q2 2022$273,000
+11.0%
19,432
+13.0%
0.11%
+54.3%
Q1 2022$246,000
-56.3%
17,198
-58.4%
0.07%
-54.5%
Q4 2021$563,000
+29.1%
41,312
+55.1%
0.15%
+36.3%
Q3 2021$436,000
-54.9%
26,642
-53.6%
0.11%
-56.9%
Q2 2021$967,00057,4620.26%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q3 2021
NameSharesValueWeighting ↓
TFG Asset Management GP Ltd 1,903,662$29,449,6525.37%
MANAGED ASSET PORTFOLIOS, LLC 1,736,416$26,862,3564.12%
Y.D. More Investments Ltd 1,381,550$21,372,5794.11%
Clean Yield Group 533,157$8,167,9653.62%
XY Capital Ltd 143,697$2,222,9931.28%
Mondrian Investment Partners LTD 4,081,715$61,225,7251.26%
Capricorn Fund Managers Ltd 204,892$3,169,6791.10%
Legacy Wealth Asset Management, LLC 124,967$1,933,2390.71%
HAP Trading, LLC 263,679$4,079,1140.65%
BRANDES INVESTMENT PARTNERS, LP 1,802,036$27,877,4930.54%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders